The EPA
Drug Initiative

Make your voice heard, urge the FDA to approve Vascepa for mixed dyslipidemia

"I strongly support the use of EPA-only Vascepa as a tool for the reduction of residual lipoprotein risk in my patients on statin therapy with triglycerides above 250 mg/dl. This treatment is safe, improves biomarkers of disease , and is being currently being evaluated by a landmark Clinical outcomes trial, REDUCE-IT."

Gregory S Pokrywka
MD FACP FNLA NCMP
Prevention of Cardiovascular Disease and Women’s Menopausal Health • Assistant Professor of General Internal Medicine • Johns Hopkins University School of Medicine • Diplomate American Board Clinical Lipidology and Fellow, National Lipid Assn. • Certified Menopause Practitioner: North American Menopause Society • Director: Baltimore Lipid Center. Board Member, South East Lipid Assn.

The Editor’s Roundtable: Hypertriglyceridemia
Vincent E. Friedewald, MDa, Christie M. Ballantyne, MDb and Peter H. Jones, MDd

Hypertriglyceridemia is defined as a fasting serum triglyceride (TG) level of ≥150 mg/dl. Serum TG elevations are designated as:

Currently, 31% of the population in the United States have TGs >150 mg/dl, unchanged for the past 2 decades. Mexican Americans have the highest rates of hypertriglyceridemia, with 9% of Mexican American men aged 50 to 59 years having very high TGs compared with 1% to 2% of the overall population with very high TGs. African-Americans have the lowest prevalence (15.6%) of hypertriglyceridemia.

Although hypertriglyceridemia affects so many persons, its clinical significance is unclear—except for the long-established relation between very high TGs and pancreatitis. Whether elevated TGs are a direct cause or only a marker for atherosclerosis has been a topic of debate for many years. This question and other issues, including evaluation and best treatment of patients with elevated TGs, are addressed in this Editor’s Roundtable.

Read More

As a person with a family history of having CVD, I have worked closely with my Doctor on reducing my risk, by lowering triglycerides, good diet, exercise and was on a statin but had to stop due to side effect, recently my doctor recommend Vascepa. I started taking Vascepa 3 months ago and for the first time I started to see a meaningful reduction with my triglycerides. Had always been in the 275mg/dL to 350 range. After my first blood work came back with triglycerides at 235mg/dl my doc and I were very excited. But to a wait and see if we would see it again on next blood work, well last week the results showed me down to 205mg. for the first time in my life, I'm 55. My insurance does not cover any cost of Vascepa so I pay out of pocket. PLEASE HELP ME AND MANY OTHERS PLEASE APPROVE FOR THOSE OF US WHO ARE BETWEEN 200mg/dL and 500mg/dL it has worked for me and others its safer than any other drug out there. Please.

Paul Holden
Chatham, NJ
Back To Top